載入...

Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer

INTRODUCTION: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have become a treatment option in non-small-cell lung cancer (NSCLC) patients. However, despite their use in this disease, a significant number of patients will eventually develop resistance and relapse. In this...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Murray, Samuel, Karavasilis, Vasilios, Bobos, Mattheos, Razis, Evangelia, Papadopoulos, Savvas, Christodoulou, Christos, Kosmidis, Paris, Fountzilas, George
格式: Artigo
語言:Inglês
出版: BioMed Central 2012
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3533816/
https://ncbi.nlm.nih.gov/pubmed/22992338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-31-77
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!